Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2019-09-13 to 2021-09-15
Current total value of award: $283546.12
Description: STUDY - MODULAR APPLICATION OF SURFACE TECHNOLOGY FOR THE GENERATION OF ANTIGEN-SPECIFIC T CELLS - BAAPMQWP#217